Search

Sartorius Stedim Biotech.

Gesloten

SectorFinanciën

211.1 -0.05

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

210.4

Max

211.2

Belangrijke statistieken

By Trading Economics

Inkomsten

-23M

93M

Verkoop

400K

745M

K/W

Sectorgemiddelde

76.531

27.91

EPS

0.94

Winstmarge

12.43

Werknemers

10,134

EBITDA

-55M

201M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+8.02% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

456M

20B

Vorige openingsprijs

211.15

Vorige sluitingsprijs

211.1

Nieuwssentiment

By Acuity

37%

63%

140 / 528 Rangschikking in Finance

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Sartorius Stedim Biotech. Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 okt 2025, 18:41 UTC

Winsten

Procter & Gamble to Focus on Innovation, Not Discounts, to Attract Wary Shoppers - 2nd Update

24 okt 2025, 18:31 UTC

Winsten

Correction to Procter & Gamble to Focus on Innovation

24 okt 2025, 16:25 UTC

Belangrijke Marktbewegers

Obook Shares Rise, Company Secures New Money Transmitter Licenses

24 okt 2025, 21:24 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

24 okt 2025, 21:24 UTC

Marktinformatie

Moody's Sees France With Increased Risk of Political Dysfunction -- Market Talk

24 okt 2025, 21:07 UTC

Winsten

The Score: Netflix, Amazon.com, Six Flags and More Stocks That Defined the Week -- WSJ

24 okt 2025, 20:58 UTC

Winsten

S&P 500 Climbs to New Record on Strong Earnings -- WSJ

24 okt 2025, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

24 okt 2025, 20:40 UTC

Winsten

Intel Expects Chip Shortages on Better PC Demand. Here's Why AMD Is Winning Too. -- Barrons.com

24 okt 2025, 20:24 UTC

Winsten

General Dyamics Stock Rises on Earnings. Aerospace Was a Standout. -- Barrons.com

24 okt 2025, 20:23 UTC

Winsten

General Dyamics Stock Rises on Earnings. Aerospace Was a Standout. -- Barrons.com

24 okt 2025, 20:13 UTC

Winsten

These Stocks Moved the Most Today: Intel, AMD, Ford, Deckers, Newmont, Nextracker, Booz Allen, Coinbase, and More -- Barrons.com

24 okt 2025, 20:07 UTC

Marktinformatie

Different-Cell Imputation Rose Proportionally in September CPI -- Market Talk

24 okt 2025, 19:40 UTC

Marktinformatie

Treasury Yields Mixed, Dollar Stronger Ahead of Fed Week -- Market Talk

24 okt 2025, 19:35 UTC

Marktinformatie

Oil Rally on U.S. Russia Sanctions Loses Steam -- Market Talk

24 okt 2025, 19:33 UTC

Winsten

IBM and Google Are Also Making Moves in Quantum. Don't Count Out the Bigger Players. -- Barrons.com

24 okt 2025, 19:29 UTC

Marktinformatie

U.S. Natural Gas Ends Week Higher on Weather Outlook -- Market Talk

24 okt 2025, 18:52 UTC

Winsten

Correction to GM Stock Soars to Record High. Earnings Were So Good, They Helped Ford. -- Barrons.com

24 okt 2025, 18:41 UTC

Winsten

GM Stock Soars to Record High. Earnings Were So Good, They Helped Ford. -- Barrons.com

24 okt 2025, 18:03 UTC

Winsten

Beyond Meat Stock Is on a Wild Ride. Why a Meme Rally Looks Undercooked. -- Barrons.com

24 okt 2025, 18:02 UTC

Winsten

Progressive Stock Got Hit After Earnings. It's Time to Buy One of America's Great Companies. -- Barrons.com

24 okt 2025, 18:00 UTC

Marktinformatie

U.S. Oil Rig Count Rises By Two to 420 -- Market Talk

24 okt 2025, 16:57 UTC

Winsten

Ford Stock Has Quadrupled Tesla's Gains. What's Behind Its Meteoric Rise. -- Barrons.com

24 okt 2025, 16:54 UTC

Marktinformatie

End to Canada-U.S. Trade Talks Not Seen Shifting Nearterm Outlook -- Market Talk

24 okt 2025, 16:44 UTC

Marktinformatie
Winsten

Amazon Retail Looks Strong as Consumer Sentiment Improves -- Market Talk

24 okt 2025, 16:39 UTC

Marktinformatie
Winsten

Amazon Sentiment Around AWS Seen as Improving in 3Q -- Market Talk

24 okt 2025, 16:33 UTC

Winsten

These Stocks Are Moving the Most Today: Intel, AMD, Ford, Deckers, Newmont, Nextracker, Booz Allen, Coinbase, and More -- Barrons.com

24 okt 2025, 16:23 UTC

Winsten

These Stocks Are Moving the Most Today: Intel, AMD, Ford, Deckers, Newmont, Nextracker, Booz Allen, Coinbase, and More -- Barrons.com

24 okt 2025, 16:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

24 okt 2025, 16:07 UTC

Winsten

Ford Stock Has Quadrupled Tesla's Gains. What's Behind Its Meteoric Rise. -- Barrons.com

Sartorius Stedim Biotech. Prognose

Koersdoel

By TipRanks

8.02% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 228.57 EUR  8.02%

Hoogste 246 EUR

Laagste 210 EUR

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor Sartorius Stedim Biotech. - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

7 ratings

5

Buy

2

Hold

0

Sell

Technische score

By Trading Central

202.7 / 211.7Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Strong Bullish Evidence

Lange Termijn

Strong Bullish Evidence

Sentiment

By Acuity

140 / 528 Rangschikking in Financiën

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
help-icon Live chat